Identification of an epithelial cell differentiation responsive region within the BZLF1 promoter of the Epstein—Barr virus

References

1. Chevallier-Greco A., Manet E., Chavrier P., Mosnier C., Daillie J., Sergeant A. 1986; Both Epstein Barr virus (EBV)-encoded trans-acting factors, EB1 and EB2, are required to activate transcription from an EBV early promoter. EMBO Journal 5:3243–3249
   [Google Scholar]
2. Countryman J., Miller G. 1985; Activation of expression of latent Epstein-Barr herpesvirus after gene transfer with a small cloned subfragment of heterogeneous viral DNA. Proceedings of the National Academy of Sciences, USA 82:4085–4089
   [Google Scholar]
3. Crawford D. H., Ando I. 1986; EB virus induction is associated with B cell maturation. Immunology 59:405–409
   [Google Scholar]
4. Dover R., Watt F. M. 1987; Measurement of the rate of epidermal terminal differentiation: expression of involucrin by S-phase keratinocytes in culture and in psoriatic plaques. Journal of Investigative Dermatology 89:349–352
   [Google Scholar]
5. Flemington E., Speck S. H. 1990a; Identification of phorbol ester response elements in the promoter of Epstein-Barr virus putative lytic switch gene BZLF1. Journal of Virology 64:1217–1226
   [Google Scholar]
6. Flemington E., Speck S. H. 1990b; Autoregulation of Epstein-Barr virus putative lytic switch gene BZLF1. Journal of Virology 64:1227–1232
   [Google Scholar]
7. Folkman J., Moscona A. 1978; Role of cell shape in growth control. Nature 273:345–349
   [Google Scholar]
8. Golden H. D., Chang R. S., Prescott W., Simpson E., Cooper T. Y. 1973; Leukocyte-transforming agent: prolonged excretion by patients with mononucleosis and excretion by normal individuals. Journal of Infectious Diseases 127:471–473
   [Google Scholar]
9. Gorman C. M., Moffat L. F., Howard B. H. 1982; Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells. Molecular and Cellular Biology 2:1044–1051
   [Google Scholar]
10. Green H. 1977; Terminal differentiation of cultured human epidermal cells. Cell 11:405–416
    [Google Scholar]
11. Henle G., Henle W., Diehl V. 1968; Relation of Burkitt’s tumour-associated herpes-type virus to infectious mononucleosis. Proceedings of the National Academy of Sciences, USA 59:94–101
    [Google Scholar]
12. Israele V., Shirley P., Sixbey J. W. 1991; Excretion of the Epstein-Barr virus from the genital tract of men. Journal of Infectious Diseases 163:1341–1343
    [Google Scholar]
13. Kieff E., Lebowitz D. 1991; Epstein-Barr virus and its replication. In Fundamental Virology 2nd edn pp 897–928 Edited by Fields B. N., Knipe D. M. New York: Raven Press;
    [Google Scholar]
14. Li Q. X., Young L. S., Nedobitek G., Dawson C. W., Birken-bach M., Wang F., Rickinson A. B. 1992; Epstein-Barr virus infection and replication in a human epithelial cell system. Nature 356:347–350
    [Google Scholar]
15. Luka J., Kallin B., Klein G. 1979; Induction of the Epstein-Barr virus (EBV) cycle in latently infected cells by n-butyrate. Virology 94:228–231
    [Google Scholar]
16. Miller G. 1990; Epstein-Barr virus. Biology, pathogenesis and medical aspects. In Virology 2nd edn, pp 1921–1958 Edited by Fields B. N., Knipe D. M. New York: Raven Press;
    [Google Scholar]
17. Montalvo E. A., Shi Y., Shenk T. E., Levine A. J. 1991; Negative regulation of the BZLF1 promoter of Epstein-Barr virus. Journal of Virology 65:3647–3655
    [Google Scholar]
18. Nederman J. C., Evans A. S., Subrahmanyan L., McCollum R. W. 1970; Prevalence, incidence and persistence of EB virus antibody in young adults. New England Journal of Medicine 282:361–365
    [Google Scholar]
19. Nedobitek G., Young L. S. 1994; Epstein-Barr virus persistence and virus-associated tumours. Lancet 343:333–335
    [Google Scholar]
20. Pattengale P. K., Smith R. W., Gerber P. 1973; Selective transformation of B lymphocytes by EB virus. Lancet ii:93–94
    [Google Scholar]
21. Pope J. H., Horne M. K., Scott W. 1968; Transformation of foetal human leucocytes in vitro by filtrates of a human leukaemia cell line containing herpes-like virus. International Journal of Cancer 3:857–866
    [Google Scholar]
22. Rheinwald J. G. 1980; Serial cultivation of normal human epidermal keratinocytes. Methods in Cell Biology 21A:229–254
    [Google Scholar]
23. Rheinwald J. G., Beckett M. A. 1980; Defective terminal differentiation in culture as a consistent and selectable character of malignant human keratinocytes. Cell 22:629–632
    [Google Scholar]
24. Rheinwald J. G., Green H. 1975; Serial cultivation of strains of human epidermal keratinocytes: the formation of keratinizing colonies from single cells. Cell 6:331–334
    [Google Scholar]
25. Rice R. H., Green H. 1979; Presence in human epidermal cells of a soluble protein precursor of the cross-linked envelope: activation of the cross-linking by calcium ions. Cell 18:681–694
    [Google Scholar]
26. Schwarz E., Freese U. K., Gissmann L., Mayer W., Roggenbuck B., Stremlau A., zur Hausen H. 1985; Structure and transcription of human papillomavirus sequences in cervical carcinoma cells. Nature 314:111–114
    [Google Scholar]
27. Shelbourn S. L., Sissons J. G. P., Sinclair J. H. 1989; Expression of oncogenic ras in human teratocarcinoma cells induces partial differentiation and permissiveness for human cytomegalovirus infection. Journal of General Virology 70:367–374
    [Google Scholar]
28. Shimizu N., Takada K. 1993; Analysis of the BZLF1 promoter of Epstein-Barr virus: identification of an anti-immunoglobulin response sequence. Journal of Virology 67:3240–3245
    [Google Scholar]
29. Sixbey J. W. 1989; Epstein-Barr virus and epithelial cells. In Advances in Viral Oncology pp 187–202 Edited by Klein G. New York: Raven Press;
    [Google Scholar]
30. Sixbey J. W., Vesterinen E. H., Nedrud J. G., Raab-Traub N., Walton L. A., Pagano J. S. 1983; Replication of Epstein-Barr virus in human epithelial cells infected in vitro . Nature 306:480–483
    [Google Scholar]
31. Sixbey J. W., Nedrud J. G., Raab-Traub N., Hanes R. A., Pagano J. S. 1984; Epstein-Barr virus replication in oropharyngeal epithelial cells. New England Journal of Medicine 310:1225–1230
    [Google Scholar]
32. Sixbey J. W., Lemon S. M., Pagano J. S. 1986; A second site for Epstein-Barr virus shedding: the uterine cervix. Lancet ii:1122–1124
    [Google Scholar]
33. Takada K., Shimizu N., Sakuma S., Ono Y. 1986; trans Activation of the latent Epstein-Barr virus (EBV) genome after transfection of the EBV DNA fragment. Journal of Virology 57:1016–1022
    [Google Scholar]
34. Tovey M. G., Lenoir G., Begon-Lours J. 1978; Activation of latent Epstein-Barr virus by antibody to human IgM. Nature 276:270–272
    [Google Scholar]
35. Urier G., Buisson M., Chambard P., Sergeant A. 1989; The Epstein-Barr virus early protein EB1 activates transcription from different responsive elements including AP-1 binding sites. EBMO Journal 8:1447–1453
    [Google Scholar]
36. Zur Hausen H., O’Neill F. J., Freese U. K. 1978; Persisting oncogenic herpesvirus induced by the tumour promoter TPA. Nature 272:373–375
    [Google Scholar]